Mindpeak
Mindpeak builds AI-powered software that automates tissue diagnostics to speed and standardize cancer detection and biomarker quantification. It uses deep learning and medical-image analysis models deployed as clinical pathology software that integrates into existing laboratory workflows and diagnostics platforms. Products target pathology laboratories and clinical research institutions, automating repetitive tasks such as cell counting, biomarker scoring, and tumor classification. The company offers regulated diagnostic software (ISO 13485 certified) designed to improve reproducibility and support pathologists’ decision-making.
Mindpeak
Mindpeak builds AI-powered software that automates tissue diagnostics to speed and standardize cancer detection and biomarker quantification. It uses deep learning and medical-image analysis models deployed as clinical pathology software that integrates into existing laboratory workflows and diagnostics platforms. Products target pathology laboratories and clinical research institutions, automating repetitive tasks such as cell counting, biomarker scoring, and tumor classification. The company offers regulated diagnostic software (ISO 13485 certified) designed to improve reproducibility and support pathologists’ decision-making.
TL;DR
What they do: AI-powered image analysis software for pathology to automate cancer detection and biomarker quantification
Founded: 2018
Headquarters / legal: Mindpeak GmbH, Hamburg
Recent funding: Series A announced Oct 2024 (~$15.3M)
Regulatory/certification: ISO 13485 certified (regulated diagnostic software)
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Digital pathology and histopathology image analysis for cancer diagnostics and biomarker quantification.
Founded
2018
Industry
Biotechnology
Tech Stack
Funding Track Record
15.3M
Series A announced October 2024 (reported amount $15.3M)
3M
Seed round announced September 2019
Investor Signal
“ZEISS Ventures; IFB Innovationsstarter; AI.FUND; Nina Capital; APEX Ventures; Motu Ventures; European Innovation Council”